{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:11:37Z","timestamp":1789708297019,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB26159"],"award-info":[{"award-number":["20242BAB26159"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB206088"],"award-info":[{"award-number":["20224BAB206088"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB206115"],"award-info":[{"award-number":["20242BAB206115"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660129"],"award-info":[{"award-number":["81660129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060335"],"award-info":[{"award-number":["82060335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060140"],"award-info":[{"award-number":["82060140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178430","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:45:45Z","timestamp":1764661545000},"page":"178430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacologic deprivation of serum inorganic phosphate ameliorates renal fibrosis via the modulation of systemic inflammation"],"prefix":"10.1016","volume":"1011","author":[{"given":"Mei-diao","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7925-9890","authenticated-orcid":false,"given":"Yuan-yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8468-1498","authenticated-orcid":false,"given":"Zi-qiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9256-3360","authenticated-orcid":false,"given":"Ze-ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-rong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-guang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1068-9433","authenticated-orcid":false,"given":"Zhi-qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-lei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-0268","authenticated-orcid":false,"given":"Qun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178430_bib1","volume":"2023","author":"Adler","year":"2010","journal-title":"Evid. base Compl. Alternative Med."},{"key":"10.1016\/j.ejphar.2025.178430_bib2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ki.2010.516","article-title":"Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases","volume":"79","author":"Barnes","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2025.178430_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/346371a0","article-title":"Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1","volume":"346","author":"Border","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178430_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107446","article-title":"Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: two randomised, placebo-controlled trials","volume":"34","author":"Bronden","year":"2020","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.ejphar.2025.178430_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2025.178430_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncpneph0098","article-title":"Obstructive nephropathy: towards biomarker discovery and gene therapy","volume":"2","author":"Chevalier","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178430_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13070503","article-title":"The protein-independent role of phosphate in the progression of chronic kidney disease","volume":"13","author":"Duayer","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.ejphar.2025.178430_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse origins of the myofibroblast\u2014implications for kidney fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178430_bib9","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1523-1755.1999.00656.x","article-title":"Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro","volume":"56","author":"Fan","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2025.178430_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2009.74","article-title":"Fibroblast activation and myofibroblast generation in obstructive nephropathy","volume":"5","author":"Grande","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178430_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ckj\/sfx074","article-title":"Sevelamer reduces endothelial inflammatory response to advanced glycation end products","volume":"11","author":"Gregorio","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejphar.2025.178430_bib13","first-page":"765","volume":"vol. 20","author":"He","year":"2009"},{"key":"10.1016\/j.ejphar.2025.178430_bib14","doi-asserted-by":"crossref","first-page":"c53","DOI":"10.1159\/000072021","article-title":"Sevelamer","volume":"94","author":"Henderson","year":"2004","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ejphar.2025.178430_bib15","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI116874","article-title":"Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney","volume":"92","author":"Isaka","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178430_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/ajkd.2001.27693","article-title":"Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis","volume":"38","author":"Jinde","year":"2001","journal-title":"Am. J. Kidney Dis. : the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.ejphar.2025.178430_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/labinvest.2008.104","article-title":"PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta","volume":"89","author":"Kawai","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2025.178430_bib18","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178430_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178430_bib20","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1681\/ASN.2008090930","article-title":"Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis","volume":"20","author":"Li","year":"2009","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.ejphar.2025.178430_bib21","article-title":"Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4\/NF-\u03baB and MAPK signaling pathways","volume":"20","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178430_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178430_bib23","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1126\/science.abb3763","article-title":"Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function","volume":"369","author":"Lobel","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178430_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14030176","article-title":"Microbiome in Chronic Kidney Disease (CKD): an omics perspective","volume":"14","author":"Lohia","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.ejphar.2025.178430_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116121","article-title":"Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells","volume":"222","author":"Lv","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178430_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.740038","article-title":"Sevelamer attenuates bioprosthetic heart valve calcification","volume":"8","author":"Meng","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2025.178430_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","article-title":"Fibroblasts and myofibroblasts in renal fibrosis","volume":"92","author":"Meran","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2025.178430_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000046093","article-title":"Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel\u00ae), a noncalcemic phosphate binder","volume":"89","author":"Nagano","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2025.178430_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1046\/j.1523-1755.1998.00076.x","article-title":"Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5\/6 nephrectomized rats","volume":"54","author":"Ng","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2025.178430_bib30","article-title":"Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats","volume":"14","author":"Nie","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178430_bib31","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.178430_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(99)00071-6","article-title":"The p38 signal transduction pathway - activation and function","volume":"12","author":"Ono","year":"2000","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178430_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis--a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejphar.2025.178430_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MNH.0b013e328344c3d4","article-title":"Mechanisms of fibrosis: the role of the pericyte","volume":"20","author":"Schrimpf","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2025.178430_bib34","article-title":"The role of the macrophage-to-myofibroblast transition in renal fibrosis","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178430_bib35","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/jcb.27714","article-title":"Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF\u2010\u03baB\/NLRP3 pathway in rats with 5\/6 subtotal nephrectomy","volume":"120","author":"Wen","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2025.178430_bib36","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.cellsig.2013.04.005","article-title":"TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification","volume":"25","author":"Workman","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2025.178430_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1081\/JDI-65259","article-title":"Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients","volume":"27","author":"Yamada","year":"2005","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejphar.2025.178430_bib38","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0002-9440(10)63586-9","article-title":"Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha","volume":"163","author":"Yuan","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.178430_bib39","series-title":"Renal Fibrosis: Mechanisms and Therapies","first-page":"253","article-title":"Myofibroblast in kidney fibrosis: origin, activation, and regulation","author":"Yuan","year":"2019"},{"key":"10.1016\/j.ejphar.2025.178430_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178430_bib41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:56:46Z","timestamp":1773856606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0014299925011847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178430","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic deprivation of serum inorganic phosphate ameliorates renal fibrosis via the modulation of systemic inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178430"}}